Published in Proc Natl Acad Sci U S A on October 20, 2008
The Effect of Riboflavin in Crohn's Disease (RISE-UP) | NCT02538354
Tolerability and Risk of Adverse Events With a Probiotic Supplement | NCT03728868
Structure, function and diversity of the healthy human microbiome. Nature (2012) 30.40
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 15.22
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75
Genetics and pathogenesis of inflammatory bowel disease. Nature (2011) 7.79
The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43
Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10
Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science (2013) 6.98
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature (2013) 6.77
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2010) 5.43
Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02
Human genetics shape the gut microbiome. Cell (2014) 4.91
The application of ecological theory toward an understanding of the human microbiome. Science (2012) 4.69
Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol (2012) 4.68
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
Has the microbiota played a critical role in the evolution of the adaptive immune system? Science (2010) 4.29
The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88
The microbiome in infectious disease and inflammation. Annu Rev Immunol (2012) 3.76
Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One (2010) 3.64
Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A (2010) 3.51
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39
The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol (2010) 3.17
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol (2011) 3.11
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Host lifestyle affects human microbiota on daily timescales. Genome Biol (2014) 2.99
Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol (2013) 2.89
Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One (2012) 2.77
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Diversity of bifidobacteria within the infant gut microbiota. PLoS One (2012) 2.71
Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis (2010) 2.62
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol (2012) 2.60
Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A (2011) 2.47
Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol (2011) 2.47
Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis (2009) 2.44
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med (2016) 2.40
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol (2009) 2.39
The immune system and the gut microbiota: friends or foes? Nat Rev Immunol (2010) 2.38
Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One (2009) 2.35
The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol (2014) 2.32
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol (2009) 2.23
Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes (2012) 2.22
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Bacterial biogeography of the human digestive tract. Sci Rep (2011) 2.18
Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol (2011) 2.15
Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A (2010) 2.10
Intestinal commensal microbes as immune modulators. Cell Host Microbe (2012) 2.07
Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol (2012) 1.98
The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe (2011) 1.97
The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity (2012) 1.97
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
The intestinal microbiome in early life: health and disease. Front Immunol (2014) 1.90
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell (2016) 1.89
Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil (2012) 1.87
Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr (2013) 1.87
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun (2016) 1.84
Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One (2012) 1.82
Microbes inside--from diversity to function: the case of Akkermansia. ISME J (2012) 1.80
Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis (2010) 1.79
How informative is the mouse for human gut microbiota research? Dis Model Mech (2015) 1.79
The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog (2010) 1.77
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut (2015) 1.76
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Host-bacterial symbiosis in health and disease. Adv Immunol (2010) 1.73
Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med (2009) 1.71
Microbiota, disease, and back to health: a metastable journey. Sci Transl Med (2012) 1.70
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One (2010) 1.70
The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg (2010) 1.69
Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol (2013) 1.68
ConStrains identifies microbial strains in metagenomic datasets. Nat Biotechnol (2015) 1.68
Spatial organization of intestinal microbiota in the mouse ascending colon. ISME J (2010) 1.66
Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol (2011) 1.65
Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One (2009) 1.60
Gut microbiota and inflammation. Nutrients (2011) 1.60
Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol (2011) 1.60
The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol (2013) 1.59
Bacterial protein signals are associated with Crohn's disease. Gut (2014) 1.58
Modulation of immune homeostasis by commensal bacteria. Curr Opin Microbiol (2011) 1.57
Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS One (2013) 1.56
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol (2013) 1.56
CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease. PLoS Biol (2014) 1.56
Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One (2013) 1.51
Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol (2012) 1.51
Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol (2010) 1.50
Advanced computational algorithms for microbial community analysis using massive 16S rRNA sequence data. Nucleic Acids Res (2010) 1.50
Intestinal microbiota regulate xenobiotic metabolism in the liver. PLoS One (2009) 1.49
Signatures of early frailty in the gut microbiota. Genome Med (2016) 1.47
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis. Proc Natl Acad Sci U S A (2014) 1.46
Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri. MBio (2015) 1.45
Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces. BMC Biol (2009) 1.45
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science (2016) 1.44
The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS One (2012) 1.43
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology (2015) 1.42
Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis (2011) 1.42
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol (2000) 8.13
Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature (2007) 7.17
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology (2004) 6.47
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol (2003) 5.87
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol (2005) 5.62
Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet (1991) 5.02
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut (2004) 4.39
Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut (2000) 4.32
Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology (1989) 3.24
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol (2007) 2.77
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun (2004) 2.47
Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis (2006) 2.45
Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis (2006) 2.38
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther (2006) 1.97
Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects. Dig Dis Sci (2006) 1.81
Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol (2001) 1.69
Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol (2006) 1.42
Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats. Br J Nutr (2007) 1.38
Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis (2007) 1.37
Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects. Gut (2005) 1.35
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut (2007) 1.29
Enterotypes of the human gut microbiome. Nature (2011) 24.36
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Towards the human intestinal microbiota phylogenetic core. Environ Microbiol (2009) 5.72
Power and limitations of the chloroplast trnL (UAA) intron for plant DNA barcoding. Nucleic Acids Res (2006) 5.31
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet (2012) 5.12
Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology (2011) 4.88
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med (2004) 4.47
Predictors of Crohn's disease. Gastroenterology (2006) 3.96
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology (2006) 3.68
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol (2002) 3.43
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39
Proof of principle for transfusion of in vitro-generated red blood cells. Blood (2011) 3.01
Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol (2005) 2.98
Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis (2005) 2.93
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology (2013) 2.78
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol (2007) 2.77
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology (2011) 2.64
Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology (2011) 2.52
Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr (2013) 2.52
Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods (2013) 2.51
The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm Bowel Dis (2014) 2.46
Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis (2006) 2.45
Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell (2012) 2.26
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol (2004) 2.21
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut (2012) 2.17
Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr (2010) 2.13
Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics (2007) 2.07
Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J Bacteriol (2004) 2.06
Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J Biol Chem (2003) 2.02
Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. Blood (2011) 1.99
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol (2009) 1.89
Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ Microbiol (2005) 1.89
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut (2010) 1.87
Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med (2012) 1.73
A key role of dendritic cells in probiotic functionality. PLoS One (2007) 1.73
Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis (2008) 1.72
Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res (2010) 1.64
Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol Ecol (2003) 1.63
Enumeration of Bacteroides species in human faeces by fluorescent in situ hybridisation combined with flow cytometry using 16S rRNA probes. Syst Appl Microbiol (2003) 1.61
Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol (2006) 1.61
Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Proteomics (2009) 1.58
Factors affecting outcomes in Crohn's disease over 15 years. Gut (2012) 1.52
Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study. Am J Gastroenterol (2008) 1.52
Long-term outcome of patients with Crohn's disease who respond to azathioprine. Clin Gastroenterol Hepatol (2012) 1.52
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study. J Infect (2013) 1.52
Saccharomyces boulardii does not prevent relapse of Crohn's disease. Clin Gastroenterol Hepatol (2013) 1.50
Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res (2003) 1.48
Raft-mediated trafficking of apical resident proteins occurs in both direct and transcytotic pathways in polarized hepatic cells: role of distinct lipid microdomains. Mol Biol Cell (2003) 1.46
Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis. Am J Gastroenterol (2007) 1.46
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact (2011) 1.45
Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production. Microb Cell Fact (2005) 1.45
Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology (2011) 1.44
Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol (2011) 1.43
Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol (2005) 1.43
Sera from patients with Crohn's disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD-2 activity. Innate Immun (2010) 1.43
A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol (2005) 1.43
A metagenomic insight into our gut's microbiome. Gut (2012) 1.43
Feeding our immune system: impact on metabolism. Clin Dev Immunol (2008) 1.42
Low species diversity and high interindividual variability in faeces of preterm infants as revealed by sequences of 16S rRNA genes and PCR-temporal temperature gradient gel electrophoresis profiles. FEMS Microbiol Ecol (2006) 1.42
Impact of lactobacilli on orally acquired listeriosis. Proc Natl Acad Sci U S A (2012) 1.38
Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis (2007) 1.37